The new paradigm of drug discovery innovation requires optimal computational methods to obtain the best clinical candidates faster.
This is not an easy task and Oxford Drug Design can help drug discovery organizations and their leaders make it a reality with our proprietary and pioneering computational platform.
We combine bold AI strategies and transformative ML technologies – validated in our own discovery programmes across multiple targets and chemical scaffold types – to help organizations innovate drug discovery more effectively and achieve lasting progress in performance for their drug discovery pipelines.